Teclistamab interference with anti-BCMA chimeric antigen receptor T-cell detection by flow cytometry: duration and clinical implications

Research output: Contribution to journalLetterContributedpeer-review

Contributors

Details

Original languageEnglish
JournalLeukemia
Volume2026
Publication statusE-pub ahead of print - 8 Apr 2026
Peer-reviewedYes

External IDs

ORCID /0000-0002-2687-9178/work/211722380
ORCID /0000-0002-4095-8649/work/211722676

Keywords